In patients with chronic nonmigraine headaches, onabotulinum toxin type A injections may reduce pain severity and frequency of headaches.
Investigators assessed the monthly onset of treatment effect for galcanezumab in the change in mean number of monthly migraine headache days.
An oral solution of celecoxib, a selective inhibitor of cyclo-oxygenase 2, is superior to placebo for the acute treatment of migraine pain.
Sleep-wake disturbances affect approximately 50% of children with acquired brain injury, and many children with preadmission chronic conditions have an increased risk for sleep-wake disturbances, a study in Pediatric Neurology suggests. A total of 78 children (median age, 9.9 years) with acquired brain injury who had been released from critical care hospitalization within 3 months…
Women account for only 18% of US medical school deans, and underrepresented racial and ethnic minorities account for only 12%.
Researchers found data that showed risk factors in episodic migraine that included annual household income.
PubMed Clinical Queries and Google Scholar search engines set to narrow search are more efficient in returning relevant and high-quality research results than standard PubMed and Google search tools.
A knowledge gap is explored by investigators as the cause of delayed treatment in migraine.
Vestibular migraine (VM) differs from migraine without vestibular symptoms in regard to mild and low frequency roll tilt (of the head) perceptual thresholds, a study in Science Reports suggests. The study enrolled patients with VM, measuring the frequency-dependence of self-motion perceptual thresholds during movements. These movements were designed to activate the canals and otolith organs…